Scotland, United Kingdom

Vijay Srirambhatla



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Location History:

  • Birmingham, GB (2017)
  • Scotland, GB (2021)
  • Edinburgh, GB (2021)

Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Vijay Srirambhatla: Innovator in Opioid Antagonist Technologies**

Introduction

Vijay Srirambhatla is a notable inventor based in Scotland, GB, with an impressive portfolio that includes three patents. His innovative work primarily focuses on the development of opioid antagonists, specifically through the creation of cocrystals and crystalline salts of naloxone and naltrexone.

Latest Patents

Srirambhatla's latest patents represent significant advancements in pain management and drug delivery systems. One of his key inventions involves cocrystals of naloxone and naltrexone, which are utilized as opioid antagonists. These cocrystals include various combinations such as naloxone isonicotinamide, naloxone hydrochloride piperazine, and naltrexone menthol, among others. Additionally, he has devised a drug-in-adhesive transdermal patch that contains fentanyl or its analogs, combined with these cocrystals to provide effective pain treatment while limiting potential abuse.

Another noteworthy patent involves crystalline salts of naloxone and naltrexone, including naloxone saccharinate and naltrexone succinate. This invention also includes the creation of a drug-in-adhesive transdermal patch aimed at the treatment of acute, chronic, or intermittent pain, highlighting Srirambhatla’s contributions toward safer opioid medication delivery.

Career Highlights

Throughout his career, Vijay Srirambhatla has worked with leading organizations in the pharmaceutical sector, such as Pain Therapeutics, Inc. and Cassava Sciences, Inc. His expertise in drug formulation and design has led to significant advancements in the field, particularly concerning the development of abuse-resistant medications.

Collaborations

Srirambhatla has collaborated with prominent figures in the industry, including Remi Barbier and Stephen William Watt. These partnerships reflect not only his commitment to innovation but also his ability to work synergistically with others to advance drug delivery technologies.

Conclusion

Vijay Srirambhatla stands out as a dedicated inventor, contributing to the vital area of opioid antagonists and pain management solutions. His latest patents showcase his ingenuity and commitment to improving healthcare outcomes, ultimately paving the way for safer and more effective treatment options for patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…